Konsyl D is contraindicated in gastroparesis patients with type 1 diabetes
Do not use Konsyl D (psyllium fiber supplement) in patients with gastroparesis. This product contains bulk-forming fiber that can worsen gastric outlet obstruction and exacerbate symptoms in patients with delayed gastric emptying 1.
Why This Is Harmful
Konsyl D is a psyllium-based bulk fiber laxative that requires adequate fluid intake and normal GI motility to work safely 1. In gastroparesis:
- Bulk fiber expands in the stomach, creating a gel-like mass that requires normal gastric emptying to pass through the pylorus
- Patients with gastroparesis already have impaired gastric motility, and adding bulk fiber can lead to bezoar formation or complete gastric outlet obstruction
- The FDA labeling explicitly warns that the product may cause choking if not taken with adequate liquid 1, and gastroparesis patients cannot reliably empty even liquids from their stomach
Additional Concerns Specific to This Patient
The high sugar content (66% sucrose, 8g per dose) makes this particularly problematic 1:
- Each dose contains 35 calories from sugar
- This creates unpredictable glycemic excursions in a patient who already struggles with erratic glucose control due to delayed and unpredictable gastric emptying
- The 2025 AGA gastroparesis guidelines emphasize optimizing glycemic control and avoiding medications that delay gastric emptying 2
What to Do Instead
The 2025 AGA guidelines recommend 2:
- Dietary modifications first: Small-particle, low-fat, low-residue diets (the opposite of bulk fiber)
- Optimize glycemic control with insulin adjustments accounting for delayed gastric emptying
- Pharmacologic options if dietary measures fail:
Common Pitfall
The inulin component might seem appealing based on research showing prebiotics can improve gut microbiota in type 1 diabetes 3, 4, 5. However, this research was conducted in patients WITHOUT gastroparesis. The mechanical obstruction risk from bulk fiber in gastroparesis far outweighs any theoretical microbiome benefit. If considering microbiome modulation, use probiotics alone (not combined with inulin/fiber) - recent meta-analyses show probiotics can reduce HbA1c by 0.54% and insulin requirements in children with type 1 diabetes 6, 7, without the mechanical risks of fiber.